Literature DB >> 27398638

PCR analysis is superior to histology for diagnosis of Whipple's disease mimicking seronegative rheumatic diseases.

P Lehmann1, B Ehrenstein1, W Hartung1, C Dragonas1, U Reischl2, M Fleck1,3.   

Abstract

OBJECTIVES: The diagnosis of Whipple's disease (WD) is commonly confirmed by histology demonstrating Periodic Acid Schiff (PAS)-positive macrophages in the duodenal mucosa. Analysis of intestinal tissue or other specimens using polymerase chain reaction (PCR) is a more sensitive method. However, the relevance of positive PCR findings is still controversial. Therefore, we evaluated the relevance of histology and PCR findings to establishing the diagnosis of WD in a series of WD patients initially presenting with suspected rheumatic diseases.
METHOD: Between 2006 and 2014, 20 patients with seronegative rheumatic diseases tested positive for Tropheryma whipplei (Tw) by PCR and/or histology and were enrolled in a retrospective analysis of the diagnostic value of both procedures.
RESULTS: Seven of the 20 cases (35%) were diagnosed with 'classic' WD as indicated by PAS-positive macrophages. In the remaining 13 patients, the presence of Tw was detected by intestinal (n = 10) or synovial PCR analysis (n = 3). Two of the 20 patients (10%) with evidence of Tw did not respond to antibiotic therapy. They were not considered to suffer from WD. Therefore, relying only on histological findings of intestinal biopsies would have missed 11 (61%) of the 18 patients with WD in our cohort. In comparison, PCR of intestinal biopsies detected Tw-DNA in 14 (93%) of the 15 WD patients evaluated. Patients with a positive histology did not differ from PCR-positive patients with regard to sex, age, or duration of disease, but more often presented with gastrointestinal symptoms.
CONCLUSIONS: A substantial number of WD patients present without typical intestinal histology findings. Additional PCR analysis of intestinal tissue or synovial fluid increased the sensitivity of the diagnostic evaluation and should be considered particularly in patients presenting with atypical seronegative rheumatic diseases and a high-risk profile for WD.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27398638     DOI: 10.1080/03009742.2016.1183038

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  6 in total

1.  Whipple's Disease: Diagnostic Value of rpoB Gene PCR from Peripheral Blood Mononuclear Cells.

Authors:  Kathleen Weigt; Alexandra Wiessner; Annette Moter; Florence Fenollar; Didier Raoult; Kristina Allers; Thomas Schneider; Verena Moos
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

2.  Fluorescence In Situ Hybridization for Diagnosis of Whipple's Disease in Formalin-Fixed Paraffin-Embedded Tissue.

Authors:  Peter Braubach; Torsten Lippmann; Didier Raoult; Jean-Christophe Lagier; Ioannis Anagnostopoulos; Steffen Zender; Florian Peter Länger; Hans-Heinrich Kreipe; Mark Philipp Kühnel; Danny Jonigk
Journal:  Front Med (Lausanne)       Date:  2017-06-22

3.  Seronegative Arthritis and Whipple Disease: Risk of Misdiagnosis in the Era of Biologic Agents.

Authors:  Luca Quartuccio; Ivan Giovannini; Stefano Pizzolitto; Maurizio Scarpa; Salvatore De Vita
Journal:  Case Rep Rheumatol       Date:  2019-10-13

4.  Diagnostic Approach for Classic Compared With Localized Whipple Disease.

Authors:  Nicholas R Crews; Kelly A Cawcutt; Bobbi S Pritt; Robin Patel; Abinash Virk
Journal:  Open Forum Infect Dis       Date:  2018-06-13       Impact factor: 3.835

5.  Potential Role for Urine Polymerase Chain Reaction in the Diagnosis of Whipple's Disease.

Authors:  Annette Moter; Matthias Janneck; Manuel Wolters; Christof Iking-Konert; Alexandra Wiessner; Christoph Loddenkemper; Björn Hartleben; Marc Lütgehetmann; Julia Schmidt; Ulrike Langbehn; Sabrina Janssen; Anika Geelhaar-Karsch; Thomas Schneider; Verena Moos; Holger Rohde; Judith Kikhney; Thorsten Wiech
Journal:  Clin Infect Dis       Date:  2019-03-19       Impact factor: 9.079

6.  Differential diagnostic value of rheumatic symptoms in patients with Whipple's disease.

Authors:  Gerhard E Feurle; Verena Moos; Andrea Stroux; Nadine Gehrmann-Sommer; Denis Poddubnyy; Christoph Fiehn; Thomas Schneider
Journal:  Sci Rep       Date:  2021-03-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.